Topper David Joseph — SEC Form 4 filings

SEC reporting owner CIK 1740378. 4 Form 4 filings on record with FilingPulse; latest filed 2025-04-03.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-04-11 to 2025-04-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Arcutis Biotherapeutics, Inc. (ARQT)Chief Financial Officer42 legs · 21,226 sh · $261,9635

Form 4 filings — Topper David Joseph

FiledFormIssuerReported transactionsSource
2025-04-034Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 9,600 @ $15.80EDGAR
2025-03-044Arcutis Biotherapeutics, Inc. (ARQT)Grant/award (A): 34,000 @ $0 · Grant/award (A): 89,000 (derivative) @ $0EDGAR
2024-09-254Arcutis Biotherapeutics, Inc. (ARQT)Grant/award (A): 60,000 @ $0 · Sale (S): 11,626 @ $9.48EDGAR
2024-04-114Arcutis Biotherapeutics, Inc. (ARQT)Grant/award (A): 110,000 @ $0 · Grant/award (A): 310,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1740378 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →